Insights

We just had to amplify this wonderful experience a user shared with us after using Owl Eye. He discovered an escalating sleep issue after starting his journey to better sleep health.  At Optalert, we built Owl Eye to help users detect signs of sleep issues within 10 minutes via a simple, straightforward test. The ideal...

We’re delighted to share that Optalert’s Owl Eye product was featured on 7NEWS! The 7NEWS feature highlighted how we developed the app, the clinical research behind it, and how Owl Eye is paving the way for accessible sleep health technology for all Australians. In the news segment, key experts described how Owl Eye worked: Paul...

Optalert is proud to introduce Owl Eye. A breakthrough in sleep science, Owl Eye provides reliable, accurate testing for signs of sleep issues within minutes. Sleep health testing at-home Owl Eye has been developed to help people with sleep issues find valuable information that helps them improve their sleep health and lead fuller lives. It...

Our team at Optalert has been dedicated to innovation in sleep science for two decades now. Today, we are proud to announce that our pioneering sleep science research team has developed a unique biomarker for rapidly detecting signs of sleep issues with astonishing accuracy. The Owl Eye test is free, easy to use, takes minutes...

Sleep is having a moment. We’ve recently seen prominent documentaries released on sleep, the emergence of sleep influencers on social media platforms, and even sleep tourism! Yes, it’s a thing. A strong driver of this increased interest is the emergence of smart devices that let people track their sleep. These devices are giving many of...

Vale Murray Johns (1937-2025) Dear Valued Customers and Partners, It is with deep sorrow and a heavy heart that I announce the passing of our visionary founder, Dr. Murray Johns, on Thursday 2nd January 2025. Murray was not only the motivating force behind the creation of Optalert, he was a pioneer in the field of...

In the final post in our three-part series about alcohol impairment, we argue that vision-based driver monitoring systems (DMSs) can accurately detect driver impairment, but not BAC.  Blood alcohol concentration (BAC) is the prevailing metric to classify a driver as unfit to drive. However, our research shows that impairment persists long after BAC declines, as...

In the second article in our three-part series on alcohol impairment, we unveil the discovery of a new biomarker: the Optalert Intoxication Scale. Optalert’s algorithm detects alcohol-related driver impairment in real-time, unlocking a new chapter in road safety. Our first article detailed how impairment persists for hours after blood alcohol concentration (BAC) declines.  The study...

In the first of our three-part series about driver intoxication, we reveal how impairment persists for hours after blood alcohol concentration falls. BAC peaked 1.5 hours after drinking alcohol, while impairment peaked at the five-hour mark. Understanding the relationship between blood alcohol concentration (BAC) and impairment is critical to improving road safety and moving us...

What is relative risk? Risk is the probability that an adverse event will occur. In the context of road safety, this refers to the risk of a traffic accident or fatality. As a driver becomes impaired by intoxication, drowsiness, or another factor, their risk of an accident increases. To quantify this increase, we look at:...